Company Quick10K Filing
ICU Medical
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-03-02
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-16
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-06
10-K 2014-12-31 Filed 2015-02-20
10-Q 2014-09-30 Filed 2014-11-10
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-07
10-K 2013-12-31 Filed 2014-02-21
10-Q 2013-09-30 Filed 2013-10-22
10-Q 2013-06-30 Filed 2013-07-25
10-Q 2013-03-31 Filed 2013-04-22
10-K 2012-12-31 Filed 2013-02-26
10-Q 2012-09-30 Filed 2012-10-19
10-Q 2012-06-30 Filed 2012-07-20
10-Q 2012-03-31 Filed 2012-04-20
10-K 2011-12-31 Filed 2012-03-23
10-Q 2011-09-30 Filed 2011-10-21
10-Q 2011-06-30 Filed 2011-07-22
10-Q 2011-03-31 Filed 2011-04-22
10-K 2010-12-31 Filed 2011-02-18
10-Q 2010-09-30 Filed 2010-10-22
10-Q 2010-06-30 Filed 2010-07-23
10-Q 2010-03-31 Filed 2010-04-23
10-K 2009-12-31 Filed 2010-02-19
8-K 2020-05-14
8-K 2020-05-07
8-K 2020-02-28
8-K 2020-02-27
8-K 2019-12-31
8-K 2019-11-12
8-K 2019-08-07
8-K 2019-07-08
8-K 2019-05-16
8-K 2019-05-09
8-K 2019-04-05
8-K 2019-03-04
8-K 2019-02-28
8-K 2018-11-15
8-K 2018-11-08
8-K 2018-08-09
8-K 2018-05-15
8-K 2018-05-09
8-K 2018-03-01
8-K 2018-01-05

ICU Medical Financials

ICUI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Integra Lifesciences (IART) 5,281 63% 33.0 2% 3,347 1,962 1,506 944 60 181 5,962
Globus Medical (GMED) 5,230 77% 24.0 10% 1,452 113 770 592 146 211 5,063
Penumbra (PEN) 4,900 67% 90.7 7% 614 147 523 353 45 53 4,788
Nuvasive (NUVA) 3,895 72% 27.0 3% 1,840 1,146 831 48 161 4,347
Tandem Diabetes Care (TNDM) 3,612 53% -179.8 -8% 293 126 330 175 -24 -19 3,455
ICU Medical (ICUI) 3,368 38% 21.1 4% 1,638 297 1,291 492 73 144 3,031
Cantel Medical (CMD) 3,193 46% 39.1 2% 1,906 1,174 950 438 42 103 4,044
Nevro (NVRO) 2,616 69% -31.3 -22% 448 250 384 263 -100 -87 2,724
Glaukos (GKOS) 2,258 87% -139.9 -6% 307 117 225 195 -19 -16 2,210
iRhythm Technologies (IRTC) 1,965 75% -37.6 -17% 310 167 198 150 -52 -49 1,841
Merit Medical Systems (MMSI) 1,715 44% 20.9 1% 1,762 812 970 425 19 101 2,119
Cardiovascular Systems (CSII) 1,707 81% 2,402.7 -1% 217 75 256 206 -3 1 1,648
Inspire Medical Systems (INSP) 1,606 82% -58.5 -16% 183 37 72 59 -29 -27 1,582
Atrion (ATRI) 1,554 35% 29.6 14% 257 24 156 55 36 50 1,490
CryoLife (CRY) 1,025 66% 50.8 0% 593 315 274 182 2 24 1,212
Orthofix Medical (OFIX) 1,001 78% -223.1 -7% 476 169 460 359 -31 -4 943
Atricure (ATRC) 999 74% -82.3 -4% 561 303 222 164 -23 -12 1,026
Luminex (LMNX) 917 56% 229.0 -2% 539 79 325 181 -10 4 851
Tactile Systems Technology (TCMD) 843 70% 76.2 5% 144 40 179 125 7 11 823
Axonics Modulation Technologies (AXNX) 827 50% -13.7 -45% 126 34 4 2 -57 -56 773

Balance Sheet ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash10885838293107121119160184193204226234244261297304316330347355367394377384401372445202241310300269327356382313314337
Accounts Receivable4849495655515253444244534953505245434135394343495856605456138125105113123150145176238230210
Inventory4138414444514943403737383637363434373838373838414449505149446401320289296289292311322330344
PP&E778381848486181184183187190193199203208210213220225224225224227225223228237237244543557588609633652674695710728749
Assets3092872873003123293463443613763934134294384524695005065205285415545706106276366636897051,4731,4871,5231,4971,4931,5261,5451,5851,6131,6231,638
Accounts Payable181817121114121113121212111112111112111211131315141319131537404578829171120134131125
Long-Term Debt757575
Liabilities413835334745299322331305297
Stockholders' Equity3213914655085806601,1981,2641,2831,3181,340
Income Statement ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue64697676717876767677818374798378737977808184869090979796248332343370372360327340331312307
Cost of Revenue37374238374141414138414138414239374139403940404241474645159243232233223209193206196208189
Gross Profit273234383537363635394142373841393638384043444648495051518988112137149152135135135104119
R&D111222223432243345554344334312131314131413131112
SG&A2019181923202022212320212326222223242220202020232222222365857777878478736866
Tax2457554845674450332527978745-10-25-10-1-11256
Net Income4891089918891212971113766710141651617191056-370505310-7312327
Cash Flow ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating10811415101128181392511151623131719121312171215272721-77489985-218051-212351
Cash Investing5153-4-26-0-245-5-17-10-9-7-1-3-2-12-11-23207-2-3611-86101-174-12-51-30-15-24-45-11-31-24
Cash Financing-23-52326-71856251315144117197-8-0917210-63-291-1730